Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
| 19.64 Delayed Data As of Jan 24 |  -0.425 / -2.12%Today’s Change | 16.71 Today|||52-Week Range 25.43 | +1.81% Year-to-Date |
Latest AMPH News | Press Releases
No recent news for Amphastar Pharmaceuticals Inc.
Today’s Trading
| Previous close | 20.07 |
| Today’s open | 20.07 |
| Day’s range | 19.49 - 20.07 |
| Volume | 275,597 |
| Average volume (3 months) | 222,442 |
| Market cap | $923.7M |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | -223.70% |
| Earnings growth (this year) | +65.87% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +22.69% |
| P/E ratio | 18.9 |
| Price/Sales | 3.13 |
| Price/Book | 2.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ODTOdonate Therapeutics... | -0.07 | -0.24% |
| AKBAAkebia Therapeutics ... | -0.64 | -7.47% |
| GOSSGossamer Bio Inc | -0.04 | -0.30% |
| KRYSKrystal Biotech Inc | -0.01 | -0.02% |
Data as of 4:00pm ET, 01/24/2020
Financials
| Next reporting date | March 18, 2020 |
| EPS forecast (this quarter) | $0.08 |
| Annual revenue (last year) | $294.7M |
| Annual profit (last year) | -$5.7M |
| Net profit margin | -1.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Rancho Cucamonga, California |
Forecasts
